Topical Bleomycin Liposome Delivery for Hair Loss and Greying

Solution Overview

Problem

Current treatments for hair loss and greying are expensive, time-consuming, have significant side effects, and are not effective in promoting hair growth or reversing greying, and there is a need for compounds that can penetrate the skin effectively, are cost-effective, easy to use, fast-acting, and well-tolerated.

Innovation Solution

A composition comprising bleomycin, encapsulated in an elastic liposome, lipid emulsion, or lipid nanoparticle carrier, applied topically to promote hair growth, treat hair loss, and darken hair, using bleomycin A2 and B2, with a surfactant like cholate, and applied 1-3 times daily for up to a year.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional hair loss treatments (Finasteride, Minoxidil) are used, then hair loss prevention is achieved, but they are expensive, have significant side effects, and only work while being used

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies bleomycin, an anti-tumour drug known for its cytotoxic properties, to treat hair loss. The drug is delivered topically using a liposome carrier system that enables controlled penetration into the scalp, converting a potentially harmful systemic drug into a beneficial localized treatment that promotes hair growth without the systemic side effects of conventional medications

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent uses liposome carriers as an intermediary delivery system for bleomycin. The liposomes encapsulate the drug and facilitate its controlled release and penetration into the scalp tissue, enabling effective local delivery while minimizing systemic absorption and associated side effects

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If steroid injections are used for alopecia areata, then hair growth is promoted, but frequent injections are needed and they cause skin thinning and decreased pigmentation

Engineering Contradiction:
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the mechanical injection method with a topical application system. Instead of injecting steroids that cause local tissue damage, the liposome-encapsulated bleomycin is applied topically and delivered through the scalp tissue, achieving hair growth promotion without the mechanical trauma and local side effects of repeated injections

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the delivery parameters of the active agent by using liposome encapsulation. This enables controlled release and penetration of the drug into the scalp, maintaining effective local concentrations for hair growth while reducing the frequency of application and avoiding the cumulative local damage associated with repeated steroid injections

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If topical treatments for hair growth are used, then they are easy to apply, but they take a long time to work and only work while being used

Engineering Contradiction:
Core Design Contradiction:
Ease of operationVSLoss of time

Solution Approach 1:

The patent employs periodic application of the liposome-encapsulated bleomycin formulation. The liposomes provide sustained release of the drug over time, maintaining effective concentrations in the scalp tissue with intermittent applications. This periodic delivery system achieves both ease of use and faster, more durable results compared to conventional topicals that require continuous daily application

Inventive Principle:
Principle #19Periodic action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The bleomycin composition effectively promotes hair growth, treats hair loss, and darkens hair without systemic side effects, maintaining results upon discontinuation, and is easy to apply and non-invasive.

Implementation Method 1

a drug delivery preparation comprising at least one anti-tumour drug (the drug typically used for treating malignant skin cancers, vulval intraepithelial neoplasia, vulval squamous cell carcinoma, actinic keratoses, keratoacanthomas, Kaposi sarcoma, Bowen's disease, and benign tumours of viral aetiology), which enables the drug to penetrate a patent's skin in effective amounts and in a more efficient manner than previously achievable

Methodology Applied
Scientific EffectLiposome encapsulation and skin penetration:

Data Source

PatentEP4157310B1Therapeutic and cosmetic topical uses of bleomycin
Publication Date: 2025.09.03
  • EP4157310B1 patent drawingFigure 1
  • EP4157310B1 patent drawingFigure 2
  • EP4157310B1 patent drawingFigure 3

AI summary

The present disclosure relates to bleomycin for use in the treatment and/or prevention of hair loss and to a composition comprising bleomycin for use in the treatment and/or prevention of hair loss. A non- therapeutic method for promoting hair generation and/or hair growth is also disclosed, the method comprising administering or applying bleomycin or a composition comprising bleomycin to an area on the subject where the promotion of hair generation and/or hair growth is desired. Further disclosed is a non-therapeutic method for darkening hair, the method comprising administering or applying bleomycin or a composition comprising bleomycin to an area on the subject where darkening of hair is desired.